Choreo LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.19M Sell
118,601
-4,427
-4% -$306K 0.11% 126
2025
Q1
$8.68M Sell
123,028
-4,936
-4% -$348K 0.13% 115
2024
Q4
$11M Buy
127,964
+79,098
+162% +$6.78M 0.16% 106
2024
Q3
$5.77M Buy
48,866
+4,128
+9% +$487K 0.08% 168
2024
Q2
$6.49M Buy
44,738
+41,111
+1,133% +$5.97M 0.11% 126
2024
Q1
$466K Buy
3,627
+519
+17% +$66.6K 0.01% 441
2023
Q4
$322K Buy
3,108
+194
+7% +$20.1K 0.01% 478
2023
Q3
$265K Sell
2,914
-58
-2% -$5.28K 0.01% 388
2023
Q2
$240K Sell
2,972
-30
-1% -$2.43K 0.01% 414
2023
Q1
$241K Buy
+3,002
New +$241K 0.01% 426